IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · IEX Real-Time Price · USD
37.62
-2.55 (-6.35%)
At close: Apr 18, 2024, 4:00 PM
38.85
+1.23 (3.27%)
After-hours: Apr 18, 2024, 7:53 PM EDT

IDEAYA Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
157.7868.7492.1572.1434.1720.616.03
Short-Term Investments
368.1296.2154.72211.5564.8969.467.2
Cash & Cash Equivalents
525.87364.94246.88283.6999.0690.0713.23
Cash Growth
44.10%47.82%-12.98%186.38%9.99%580.88%-
Receivables
0.020.211.11.88000
Other Current Assets
6.745.313.023.042.590.60.35
Total Current Assets
532.63370.45251288.61101.6590.6713.58
Property, Plant & Equipment
8.418.998.669.489.75.153.74
Long-Term Investments
107.498.32121.2901.5300
Other Long-Term Assets
0.780.210.40.190.120.720.16
Total Long-Term Assets
116.6817.52130.359.6611.355.873.9
Total Assets
649.32387.97381.35298.2711396.5417.48
Accounts Payable
6.64.282.10.950.711.420.66
Current Debt
1.751.871.71.541.1500
Other Current Liabilities
18.7625.5741.3636.155.0941.77
Total Current Liabilities
27.131.7245.1638.646.945.412.43
Long-Term Debt
1.131.613.485.185.6300
Other Long-Term Liabilities
05.1931.1956.170.031.694.7
Total Long-Term Liabilities
1.136.834.6761.365.661.694.7
Total Liabilities
28.2338.5179.8310012.67.17.13
Total Debt
2.873.485.186.726.7700
Debt Growth
-17.52%-32.79%-22.94%-0.72%---
Retained Earnings
-348.36-235.4-176.75-126.99-92.49-50.52-16.17
Comprehensive Income
0.56-2.87-0.710.010.07-0.03-0
Shareholders' Equity
621.09349.46301.51198.27100.4-48.95-15.74
Net Cash / Debt
523361.45241.7276.9792.2990.0713.23
Net Cash / Debt Growth
44.69%49.55%-12.74%200.11%2.47%580.88%-
Net Cash Per Share
9.098.726.8611.207.3894.1919.02
Working Capital
505.53338.74205.84249.9794.7185.2511.14
Book Value Per Share
10.808.438.558.028.03-51.19-22.63
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).